Can I read HCV lookback in the United States: effectiveness of an extended lookback program on EtoBox?

HCV lookback in the United States: effectiveness of an extended lookback program by Delia Menozzi; Troy Udulutch; Augusto E. Llosa; Susan A. Galel is a Medicine article available to read on EtoBox.

What is HCV lookback in the United States: effectiveness of an extended lookback program about?

## Background: In 1998, the fda recommended look-back for hcv. the recommendation was initially limited, however, to donors who reacted on a multiantigen hcv screening test and to components collected since january 1, 1988. a lookback program was extended to include donors who reacted on the first-generation (single-antigen) hcv screening test and who were positive on a supplemental assay (riba-1 or -2) and all components for which transfusion records could be found (back to 1978). ## Study design and methods: The yield of the incremental lookback programs was compared to that originally recommended by the fda by comparing the number of newly identified hcv-positive recipients in each program. the results of lookbacks were reviewed on 385 blood components for which 314 transfusion recipients were identified. ## Results: Of the 135 recipients in the fda program, 70 percent were dead, 28 percent were living and notified, and 2 percent could not be located. in the incremental programs, there were 179 recipients, of whom 80.4 percent were dead, 16.2 percent were living and notified, and 3.4 percent could not be located. most adult recipients were dead (81%), but the majority of pediatr

Who reads HCV lookback in the United States: effectiveness of an extended lookback program?

Author

Delia Menozzi; Troy Udulutch; Augusto E. Llosa; Susan A. Galel

Publisher

Elsevier Science; John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Elsevier; Elsevier BV; Wiley (ISSN 0372-1248)

Published

2000

Language

EN

Field

Medicine (Health Sciences)